Yale Prof Is First Woman To Win Warren Prize

Joan A. Steitz, professor of molecular biophysics and biochemistry at the School of Medicine at Yale University, New Haven, Conn., is the first woman ever to win the 118-year-old Warren Prize, presented every three years by Massachusetts General Hospital in Boston. Steitz, 48, will share the 1989 prize with the 1989 Nobel laureate in chemistry, Thomas R. Cech, professor of chemistry at the University of Colorado. Prize winners receive a plaque and $2,500. Steitz, an investigator with the Howar

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Joan A. Steitz, professor of molecular biophysics and biochemistry at the School of Medicine at Yale University, New Haven, Conn., is the first woman ever to win the 118-year-old Warren Prize, presented every three years by Massachusetts General Hospital in Boston. Steitz, 48, will share the 1989 prize with the 1989 Nobel laureate in chemistry, Thomas R. Cech, professor of chemistry at the University of Colorado. Prize winners receive a plaque and $2,500.

Steitz, an investigator with the Howard Hughes Medical Institute Laboratory, received the Warren Prize for her work on the structure and function of ribonucleic acid (RNA). Through her research, she determined that certain RNA components - small nuclear ribonucleoproteins, or "snRNPs" - serve a variety of functions within the cell. The most important function of these clusters of proteins is to moderate gene expression, the process through which cells turn genes on and off. Further research on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies